Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAUFIN: Once-Daily vs Twice-Daily Nevirapine-Based ART in HIV
NCT00199979Phase 3Unknown
- Sponsor
- Medex
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Medex. Status: unknown.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00199979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199979.